VIR

Conviction 80HealthcareScan · Fri, Jun 26, 2026

VIR$10.08+2.02%

ResistanceSupportVol 14Insider sell

Vol MA14 2.74M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Vir Biotechnology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vir.bio ↗

Price10.08

Change+2.02%

Gap+0.61%

Rel volume3.88×

Avg volume2.49M

Avg $ vol23.09M

SMA 209.08

SMA 509.49

SMA 2007.57

Price vs 50+6.25%

Price vs 200+33.13%

MA stackbullish

50/200 cross—

Supertrendup · 8.63

RSI (14)62

MACD hist0.18

MACD crossbull · 6d

Stoch %K / %D86 / 81

ADX (14)23

+DI / −DI29 / 14

RSI divergenceBullish

MACD divergenceBullish

ATR %+4.82%

ADR %5.09%

52w high11.09

52w low4.28

From 52w high-9.11%

Above 52w low+135.51%

New 52w highNo

SqueezeOff

Bollinger width25.81%

%B0.93

Donchian pos86.29%

Donchian high10.39

Donchian low8.16

AVWAP (52w high)9.53

vs AVWAP high+5.80%

AVWAP (52w low)7.91

vs AVWAP low+27.43%

OBV trendFlat

Chaikin MF (20)-0.27

Today vs 20d3.88×

Avg vol (14d)2.74M

Avg vol (20d)2.49M

Avg $ vol (20d)23.09M

Market cap—

RS 3m (vs SPY)-1.90%

RS 6m (vs SPY)+57.17%

RS line new highNo

Trend template7/8

Technical rank84.7

1 week+10.04%

1 month+10.77%

3 months+12.50%

6 months+68.28%

1 year+94.22%

YTD+69.70%

P/E-3.80

P/B2.05

P/S24.27

P/FCF-4.19

EPS-3.16

Div yield—

ROE-53.89%

ROA-42.71%

Debt/Eq—

Current7.11

EV/EBITDA-2.97

Gross margin—

Net margin-638.87%

Rev growth-7.61%

EPS growth16.09%

Price target21.43

Target upside117.23%

Analyst ratingBuy

Institutional90.86%

Ent. value1.39B

Revenue240K

Net income-125.69M

Gross profit—

Free cash flow-396.61M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out168.65M

Employees367

ListedFri, Oct 11, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank84.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.42

Support8.33

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VIR

All disclosures →

No recent disclosed trades by Congress in VIR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VIR · 7 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Coughlin Timothy Director · Stock Option (Right to Buy) · 2026-06-09	Grant	16K	$0	2026-06-09	2026-06-10
Coughlin Timothy Director · Common Stock · 2026-06-09	Grant	8K	$0	2026-06-09	2026-06-10
Sabatini Brent SVP, Chief Accounting Officer · Common Stock · 2026-06-01	Sell	379	$4K	2026-06-01	2026-06-02
Napolitano Janet Director · Common Stock · 2026-06-01	Sell	3.2K	$30K	2026-06-01	2026-06-02
Napolitano Janet Director · Common Stock · 2026-05-27	Grant	8K	$0	2026-05-27	2026-05-28
BISCHOFBERGER NORBERT W Director · Stock Option (Right to Buy) · 2026-05-27	Grant	16K	$0	2026-05-27	2026-05-28
MORE ROBERT J Director · Stock Option (Right to Buy) · 2026-05-27	Grant	16K	$0	2026-05-27	2026-05-28
MORE ROBERT J Director · Common Stock · 2026-05-27	Grant	8K	$0	2026-05-27	2026-05-28
Sigal Charles Elliott Director · Common Stock · 2026-05-27	Grant	8K	$0	2026-05-27	2026-05-28
BISCHOFBERGER NORBERT W Director · Common Stock · 2026-05-27	Other	—	—	2026-05-27	2026-05-28

SEC filings

EDGAR filings in VIR · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.